Wealthspire Advisors (Maryland)’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-288
Closed -$12K 1009
2019
Q1
$12K Buy
288
+112
+64% +$4.17K ﹤0.01% 1455
2018
Q4
$6K Sell
176
-240
-58% -$9.69K ﹤0.01% 1652
2018
Q3
$21K Buy
416
+58
+16% +$2.9K ﹤0.01% 1291
2018
Q2
$18K Buy
358
+20
+6% +$1.01K ﹤0.01% 1349
2018
Q1
$17K Buy
338
+18
+6% +$960 ﹤0.01% 1343
2017
Q4
$17K Buy
320
+14
+5% +$696 ﹤0.01% 1373
2017
Q3
$15K Buy
306
+46
+18% +$2.19K ﹤0.01% 1405
2017
Q2
$13K Buy
260
+14
+6% +$645 ﹤0.01% 1431
2017
Q1
$10K Sell
246
-3,080
-93% -$127K ﹤0.01% 1338
2016
Q4
$140K Sell
3,326
-180
-5% -$7.34K 0.02% 477
2016
Q3
$153K Hold
3,506
0.02% 459
2016
Q2
$153K Buy
3,506
+610
+21% +$26.3K 0.03% 435
2016
Q1
$128K Buy
2,896
+2,820
+3,711% +$119K 0.02% 470
2015
Q4
$3K Buy
+76
New +$3.2K ﹤0.01% 1455

Other funds holding FMS

Wealthspire Advisors (Maryland)'s FMS Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Fresenius Medical Care (FMS) in Q2 2019, closing a stake of 288 shares — an estimated $12K sold.

Wealthspire Advisors (Maryland) first reported a position in FMS in Q4 2015 and held it in 14 quarters. The position peaked at $153K in Q3 2016. 175 funds tracked by Wall St. Rank hold FMS as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Fresenius Medical Care position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 288 Fresenius Medical Care shares in Q2 2019, an estimated $12K.
  • Wealthspire Advisors (Maryland) first reported a position in Fresenius Medical Care in Q4 2015 and held it in 14 quarters.
  • Wealthspire Advisors (Maryland)'s Fresenius Medical Care position peaked at $153K in Q3 2016.
  • 175 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.